Current and future management of EGFR-positive NSCLC - European Medical Journal

Current and future management of EGFR-positive NSCLC

Oncology

With: Dr. Sackier (Moderator), Dr. Moreno (KOL) and Prof. Vansteenkiste (KOL)

Job bag: CP-329213

Date of prep: July 2022

This educational webinar has been organised and funded by The Janssen Pharmaceutical Companies of Johnson & Johnson. The content of the webinar has not been approved for distribution to United Kingdom (UK) healthcare professionals.

 

 

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>